Crossmark Global Holdings Inc. increased its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 14.8% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,476 shares of the semiconductor company’s stock after buying an additional 1,225 shares during the period. Crossmark Global Holdings Inc.’s holdings in Synopsys were worth $4,675,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also added to or reduced their stakes in the stock. Orion Porfolio Solutions LLC raised its stake in Synopsys by 16.3% during the third quarter. Orion Porfolio Solutions LLC now owns 29,903 shares of the semiconductor company’s stock valued at $14,754,000 after buying an additional 4,197 shares during the last quarter. KCM Investment Advisors LLC grew its stake in shares of Synopsys by 4.3% in the third quarter. KCM Investment Advisors LLC now owns 706 shares of the semiconductor company’s stock worth $348,000 after acquiring an additional 29 shares during the last quarter. Amova Asset Management Americas Inc. increased its holdings in shares of Synopsys by 41.7% during the third quarter. Amova Asset Management Americas Inc. now owns 22,410 shares of the semiconductor company’s stock valued at $11,058,000 after acquiring an additional 6,590 shares in the last quarter. Trust Asset Management LLC raised its position in shares of Synopsys by 19.1% in the 3rd quarter. Trust Asset Management LLC now owns 2,104 shares of the semiconductor company’s stock worth $1,038,000 after purchasing an additional 338 shares during the last quarter. Finally, GW&K Investment Management LLC boosted its stake in Synopsys by 26.6% in the 3rd quarter. GW&K Investment Management LLC now owns 176 shares of the semiconductor company’s stock worth $87,000 after purchasing an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $437.41 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. The firm has a market cap of $83.79 billion, a price-to-earnings ratio of 67.92, a price-to-earnings-growth ratio of 3.60 and a beta of 1.15. The business has a 50-day simple moving average of $466.71 and a two-hundred day simple moving average of $470.69. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 4,157 shares of company stock worth $1,945,036. 0.56% of the stock is owned by insiders.
Analyst Ratings Changes
SNPS has been the topic of several recent analyst reports. Piper Sandler cut their price objective on shares of Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a research report on Thursday, February 26th. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a report on Friday, February 20th. Morgan Stanley reiterated an “equal weight” rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the company a “buy” rating in a research report on Wednesday, February 25th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $531.00.
Check Out Our Latest Stock Analysis on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
